lobbying_activities: 2461863

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2461863	615e7c3c-2939-4128-9b11-08791624ac32	Q2	BLUEBIRD STRATEGIES	401105447	PEAR THERAPEUTICS	2020	second_quarter	MMM	H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2020-07-07T14:18:45.297000-04:00